Loading...
•
Jun 30, 2023
Seer Q2 2023 Earnings Report
Reported an 11% increase in revenue compared to the prior year period and launched the Proteograph XT Assay Kit.
Key Takeaways
Seer, Inc. reported revenue of $4.0 million for Q2 2023, an 11% increase year-over-year. The company launched the Proteograph XT Assay Kit and introduced the Seer Technology Access Center (STAC). They ended the quarter with $396 million in cash, cash equivalents and investments. The company expects full year 2023 revenue to be in the range of $16 million to $18 million.
Achieved revenue of $4.0 million for the second quarter of 2023, an increase of 11% over the prior year period.
Launched the Proteograph XT Assay Kit, enabling rapid proteomics across a range of sample types and species.
Introduced the Seer Technology Access Center, providing mass spec services and end-to-end solutions.
Expanded collaboration with Thermo Fisher Scientific to develop and optimize proteomics and proteogenomics workflows.
Revenue by Segment
Forward Guidance
Seer now expects full year 2023 revenue to be in the range of $16 million to $18 million, representing growth of 10% at the mid-point of the range over full year 2022.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...